Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis

Diabetes Care

Volumn 32, Issue 4, 2009, Pages 617-622

  Poppe, Alexandre Y ^a   Majumdar, Sumit R ^b   Jeerakathil, Thomas ^b   Ghali, William ^a   Buchan, Alastair M ^c   Hill, Michael D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROBABILITY; PROSPECTIVE STUDY; RISK FACTOR; STROKE; STROKE PATIENT;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CANADA; CEREBRAL HEMORRHAGE; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 65349175045     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1754     Document Type: Article

References (25)

1. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein H: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426-2432, 2001
2. Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Shuaib A, Ashwood T, Wasiewski W, Alderfer V, Hårdemark HG, Rodichok L: NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 39:1751-1758, 2008
3. Stead LG, Gilmore RM, Bellolio MF, Mishra S, Bhagra A, Vaidyanathan L, Decker WW, Brown RD Jr: Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit Care. 21 March 2008 [Epub ahead of print]
4. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg S: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59:669-674, 2002
5. Demchuk AM, Morgenstern LB, Krieger DW, Linda Chi T, Hu W, Wein TH, Hardy RJ, Grotta JC, Buchan A: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 30:34-39, 1999
6. Yong M, Kaste M: Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 39:2749-2755, 2008
7. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks E: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115:e478-e534, 2007
8. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams L: Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 39:384-389, 2008
9. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti K: Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 6:397-406, 2007
10. Uyttenboogaart M, Koch MW, Stewart RE, Vroomen PC, Luijckx GJ, Keyser JD: Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 130:1626-1630, 2007
11. Kase CS, Furlan AJ, Wechlser L: Cerebral hemorrhage after intraarterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 57:1603-1610, 2001
12. Els T, Klisch J, Orszagh M, Hetzel A, Schulte-Monting J, Schumacher M, Lucking C: Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis 13: 89-94, 2002
13. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, Codina A, Quintana M: Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 34:1235-1241, 2003
14. Leigh R, Zaidat OO, Suri MF, Lynch G, Sundararajan S, Sunshine H, Tarr R, Selman W, Landis DM, Suarez J: Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 35:1903-1907,2004
15. Saposnik G, Young B, Silver B, Di Legge S, Webster F, Beletsky V, Jain V, Nilanont Y, Hachinski V: Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA 292: 1839-1844, 2004
16. Hill MD, Buchan A: Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 172:1307-1312, 2005
17. Norris JW BA, Cote R, Hachinski V, Phillips SJ, Shuaib A, Silver F, Simard D, Teal P: Canadian guidelines for intravenous thrombolytic treatment in acute stroke: a consensus statement of the Canadian Stroke Consortium. Can J Neurol Sci 25: 257-259, 1998
18. Barber PA, Demchuk AM, Zhang J, Buchan A: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group: Alberta Stroke Programme Early CT Score. Lancet 355: 1670 -1674, 2000
19. Weir GJ, Murray GD, Dyker AG, Lees K: Is hyperglycaemia an independent predictor of poor outcome after acute stroke: results of a long-term follow-up study. BMJ 314:1303-1306, 1997
20. Dzialowski I, Pexman JH, Barber PA, Dem-chuk AM, Buchan AM, Hill M, CASES Investigators: Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry. Stroke 38:75-79, 2007
21. Dietrich WD, Alonso O, Busto R: Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 24:111-116, 1993
22. Allport LE, Butcher KS, Baird TA, MacGregor L, Desmond PM, Tress BM, Colman P, Davis S: Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 35: 1886-1891, 2004
23. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus J: Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117:1018 -1027, 2008
24. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, Torremocha F, Herpin D, Marechaud R: Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 21:305-310, 2004
25. Lacara T, Domagtoy C, Lickliter D, Quattrocchi K, Snipes L, Kuszaj J, Prasnikar M: Comparison of point-of care and laboratory glucose analysis in critically ill patients Am J Crit Care 16: 336-346, 2007